Cargando…
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
BACKGROUND AND AIMS: Epicardial and pericardial adipose tissue (EAT and PAT) associate with atherosclerosis, however, discussed to have different inflammatory properties. We examined the NLRP3 inflammasome related pathway, playing a pivotal role in atherosclerosis, in EAT, PAT and subcutaneous AT (S...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833236/ https://www.ncbi.nlm.nih.gov/pubmed/36644557 http://dx.doi.org/10.1016/j.athplu.2022.03.005 |
_version_ | 1784868195084009472 |
---|---|
author | Åkra, Sissel Seljeflot, Ingebjørg Braathen, Bjørn Bratseth, Vibeke Hansen, Charlotte Holst Arnesen, Harald Tønnessen, Theis Solheim, Svein |
author_facet | Åkra, Sissel Seljeflot, Ingebjørg Braathen, Bjørn Bratseth, Vibeke Hansen, Charlotte Holst Arnesen, Harald Tønnessen, Theis Solheim, Svein |
author_sort | Åkra, Sissel |
collection | PubMed |
description | BACKGROUND AND AIMS: Epicardial and pericardial adipose tissue (EAT and PAT) associate with atherosclerosis, however, discussed to have different inflammatory properties. We examined the NLRP3 inflammasome related pathway, playing a pivotal role in atherosclerosis, in EAT, PAT and subcutaneous AT (SAT), their relationship to cell types and anthropometric measures in patients undergoing coronary artery bypass grafting. METHODS: Biopsies from EAT, PAT and SAT were collected from 52 patients with coronary heart disease (CHD) (median body weight 85.0 kg) and 22 controls. RNA was extracted and expression of interleukin (IL)-1β, IL-18, NLRP3, Caspase-1, toll-like receptor 4 (TLR4), IL-6, IL-6 receptor and gp130 were analyzed by RT-PCR. RESULTS: Limited differences in any genes between CHD patients and controls. IL-18 and IL-6 were 4-fold higher expressed in EAT versus PAT (p < 0.01, both) and SAT (p < 0.001, both), whereas caspase-1, IL-6R and gp130 were higher expressed in SAT compared to the other compartments (all p = 0.06-<0.001). Significant correlations between SAT and PAT gene expressions (r = 0.358–0.579, all p ≤ 0.01). Especially NLRP3 and TLR4 associated with the expression of macrophages in all compartments (all p < 0.001). In EAT IL-18 correlated inversely with the expression of macrophages and T-cells. In SAT and PAT most of the mediators associated with body weight. CONCLUSIONS: Higher expression of IL-18 and IL-6 was observed in EAT in our non-obese CHD patients, not related to inflammatory cells. The NLRP3 inflammasome activation in SAT that mirrored PAT, both related to anthropometrics, suggest that SAT samples, being easily available, to a certain degree, represent adipose tissue inflammation in general. |
format | Online Article Text |
id | pubmed-9833236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98332362023-01-12 The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery Åkra, Sissel Seljeflot, Ingebjørg Braathen, Bjørn Bratseth, Vibeke Hansen, Charlotte Holst Arnesen, Harald Tønnessen, Theis Solheim, Svein Atheroscler Plus Full Length Article BACKGROUND AND AIMS: Epicardial and pericardial adipose tissue (EAT and PAT) associate with atherosclerosis, however, discussed to have different inflammatory properties. We examined the NLRP3 inflammasome related pathway, playing a pivotal role in atherosclerosis, in EAT, PAT and subcutaneous AT (SAT), their relationship to cell types and anthropometric measures in patients undergoing coronary artery bypass grafting. METHODS: Biopsies from EAT, PAT and SAT were collected from 52 patients with coronary heart disease (CHD) (median body weight 85.0 kg) and 22 controls. RNA was extracted and expression of interleukin (IL)-1β, IL-18, NLRP3, Caspase-1, toll-like receptor 4 (TLR4), IL-6, IL-6 receptor and gp130 were analyzed by RT-PCR. RESULTS: Limited differences in any genes between CHD patients and controls. IL-18 and IL-6 were 4-fold higher expressed in EAT versus PAT (p < 0.01, both) and SAT (p < 0.001, both), whereas caspase-1, IL-6R and gp130 were higher expressed in SAT compared to the other compartments (all p = 0.06-<0.001). Significant correlations between SAT and PAT gene expressions (r = 0.358–0.579, all p ≤ 0.01). Especially NLRP3 and TLR4 associated with the expression of macrophages in all compartments (all p < 0.001). In EAT IL-18 correlated inversely with the expression of macrophages and T-cells. In SAT and PAT most of the mediators associated with body weight. CONCLUSIONS: Higher expression of IL-18 and IL-6 was observed in EAT in our non-obese CHD patients, not related to inflammatory cells. The NLRP3 inflammasome activation in SAT that mirrored PAT, both related to anthropometrics, suggest that SAT samples, being easily available, to a certain degree, represent adipose tissue inflammation in general. Elsevier 2022-03-24 /pmc/articles/PMC9833236/ /pubmed/36644557 http://dx.doi.org/10.1016/j.athplu.2022.03.005 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Full Length Article Åkra, Sissel Seljeflot, Ingebjørg Braathen, Bjørn Bratseth, Vibeke Hansen, Charlotte Holst Arnesen, Harald Tønnessen, Theis Solheim, Svein The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery |
title | The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery |
title_full | The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery |
title_fullStr | The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery |
title_full_unstemmed | The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery |
title_short | The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery |
title_sort | nlrp3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery |
topic | Full Length Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833236/ https://www.ncbi.nlm.nih.gov/pubmed/36644557 http://dx.doi.org/10.1016/j.athplu.2022.03.005 |
work_keys_str_mv | AT akrasissel thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT seljeflotingebjørg thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT braathenbjørn thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT bratsethvibeke thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT hansencharlotteholst thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT arnesenharald thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT tønnessentheis thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT solheimsvein thenlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT akrasissel nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT seljeflotingebjørg nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT braathenbjørn nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT bratsethvibeke nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT hansencharlotteholst nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT arnesenharald nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT tønnessentheis nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery AT solheimsvein nlrp3inflammasomeactivationinsubcutaneousepicardialandpericardialadiposetissueinpatientswithcoronaryheartdiseaseundergoingcoronarybypasssurgery |